Electronic Case Reporting (eCR)
3.0.0-ballot - United States of America flag

Electronic Case Reporting (eCR), published by HL7 International / Public Health. This guide is not an authorized publication; it is the continuous build for version 3.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/case-reporting/ and changes regularly. See the Directory of published versions

ValueSet: HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM) (Experimental)

Official URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1600-example Version: 3.0.0-ballot
Standards status: Informative Active as of 2025-11-20 Computable Name: ValueSetHIVARVIntegraseINSTIExample
Other Identifiers: OID:2.16.840.1.113762.1.4.1146.1600

Usage: Clinical Focus: Human immunodeficiency virus (HIV) infection category B1, Reporting: Triggering, Priority: Routine

HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM)

References

Logical Definition (CLD)

  • Include these codes as defined in http://www.nlm.nih.gov/research/umls/rxnorm version Not Stated (use latest from terminology server)
    CodeDisplay
    1235588raltegravir 100 MG Chewable Tablet
    1235591raltegravir 100 MG Chewable Tablet [Isentress]
    1235593raltegravir 25 MG Chewable Tablet
    1235595raltegravir 25 MG Chewable Tablet [Isentress]
    1433873dolutegravir 50 MG Oral Tablet
    1433879dolutegravir 50 MG Oral Tablet [Tivicay]
    1486838raltegravir 100 MG Granules for Oral Suspension
    1486841raltegravir 100 MG Granules for Oral Suspension [Isentress]
    1796077dolutegravir 10 MG Oral Tablet
    1796079dolutegravir 10 MG Oral Tablet [Tivicay]
    1796081dolutegravir 25 MG Oral Tablet
    1796083dolutegravir 25 MG Oral Tablet [Tivicay]
    1924313raltegravir 600 MG Oral Tablet
    1924315raltegravir 600 MG Oral Tablet [Isentress]
    2374562dolutegravir 5 MG Tablet for Oral Suspension
    2374566dolutegravir 5 MG Tablet for Oral Suspension [Tivicay]
    2475199cabotegravir 30 MG Oral Tablet
    2475205cabotegravir 30 MG Oral Tablet [Vocabria]
    744842raltegravir 400 MG Oral Tablet
    744846raltegravir 400 MG Oral Tablet [Isentress]
    1999667bictegravir 50 MG / emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet
    1999673bictegravir 50 MG / emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet [Biktarvy]

 

Expansion

This value set expansion contains 22 concepts.

SystemVersionCodeDisplayJSONXML
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1235588
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1235591
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1235593
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1235595
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1433873
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1433879
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1486838
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1486841
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1796077
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1796079
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1796081
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1796083
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1924313
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1924315
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  2374562
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  2374566
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  2475199
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  2475205
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  744842
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  744846
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1999667
http://www.nlm.nih.gov/research/umls/rxnorm2022-01  1999673

Description of the above table(s).